Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-09

Clinical Trial Update: Bintrafusp Alfa Monotherapy in Platinum-Experienced Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for bintrafusp alfa monotherapy in platinum-experienced cervical cancer (uterine cervical neoplasms) with completed status and results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bintrafusp alfa (bintrafusp alfa)

Snippet

Sponsor: EMD Serono Research & Development Institute, Inc. | Conditions: Uterine Cervical Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2023-05-09